1383. Everolimus is Associated with an Increased Risk of Tuberculosis in Solid-Organ Transplant Recipients

BACKGROUND: Tuberculosis (TB) is an important post-transplant infection. Everolimus has been documented to reduce the risk of cytomegalovirus infection in transplant recipients, but its impact on other infections is less known. The present study aimed to assess immunosuppressive regimens on TB risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hsin-Yun, Cheng, Aristine, Wang, So-Meng, Tsai, Meng-Kun, Chen, Yih-Sharng, Wang, Sheoi-Shen, Ho, Cheng-Maw, Hu, Rey-Heng, Hsu, Hsao-Hsun, Fang, Chi-Tai, Chen, Yee-Chun, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808879/
http://dx.doi.org/10.1093/ofid/ofz360.1247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808879/
http://dx.doi.org/10.1093/ofid/ofz360.1247

Ejemplares similares